Market revenue in 2023 | USD 0.9 million |
Market revenue in 2030 | USD 2.2 million |
Growth rate | 14.3% (CAGR from 2023 to 2030) |
Largest segment | Neurology |
Fastest growing segment | Orthopedic |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Dental, Orthopedic, Neurology |
Key market players worldwide | GlaxoSmithKline, Hewlett Packard Enterprise Co, Merck KGaA, AstraZeneca PLC, Aprecia Pharmaceuticals, Extend Biosciences, BioDuro, Affini-T Therapeutics, Osmotica Pharmaceutical, FabRx, Cycle Pharmaceuticals |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to 3d printed drugs market will help companies and investors design strategic landscapes.
Neurology was the largest segment with a revenue share of 44.44% in 2023. Horizon Databook has segmented the Sweden 3d printed drugs market based on dental, orthopedic, neurology covering the revenue growth of each sub-segment from 2018 to 2030.
In Sweden, the growing ecosystem of innovation and collaboration in pharmaceutical and healthcare sectors is a key driver of 3D printed drugs market. Sweden has a strong reputation for fostering a culture of research, development, and innovation, especially in the fields of healthcare and technology.
By leveraging 3D printing, Sweden is contributing to advancements in personalized medicine. Moreover, Sweden's strategic alliances and partnerships with academia, industry, and government bodies drive research and innovation in 3D printing technology for pharmaceuticals.
Furthermore, the healthcare system in Sweden focuses on developing patient-centric solutions and improving accessibility to healthcare, which is expected to boost the demand for 3D printed drugs that can be tailored to efficiently and cost-effectively meet individual patient needs.
Horizon Databook provides a detailed overview of country-level data and insights on the Sweden 3d printed drugs market , including forecasts for subscribers. This country databook contains high-level insights into Sweden 3d printed drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account